Yüklüyor......
Does tumor profile in gastric and gastroesophageal (GE) junction cancer justify off-label use of targeted therapy?—a narrative review
Despite significant therapeutic progress, gastric cancer remains among the most deadly forms of cancer encountered in clinical practice, and this remains true even in the context of declining incidence. Outcomes in advanced disease remain poor and therapy is rarely curative in this setting. As our u...
Kaydedildi:
| Yayımlandı: | Ann Transl Med |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7575969/ https://ncbi.nlm.nih.gov/pubmed/33145329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-3510 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|